1. Home
  2. MBRX vs BACK Comparison

MBRX vs BACK Comparison

Compare MBRX & BACK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MBRX
  • BACK
  • Stock Information
  • Founded
  • MBRX 2015
  • BACK 2000
  • Country
  • MBRX United States
  • BACK United States
  • Employees
  • MBRX N/A
  • BACK N/A
  • Industry
  • MBRX Biotechnology: Pharmaceutical Preparations
  • BACK Medical Specialities
  • Sector
  • MBRX Health Care
  • BACK Health Care
  • Exchange
  • MBRX Nasdaq
  • BACK Nasdaq
  • Market Cap
  • MBRX 1.4M
  • BACK 1.6M
  • IPO Year
  • MBRX 2016
  • BACK 2019
  • Fundamental
  • Price
  • MBRX $1.28
  • BACK $0.66
  • Analyst Decision
  • MBRX Strong Buy
  • BACK
  • Analyst Count
  • MBRX 2
  • BACK 0
  • Target Price
  • MBRX $24.00
  • BACK N/A
  • AVG Volume (30 Days)
  • MBRX 13.3M
  • BACK 4.2M
  • Earning Date
  • MBRX 03-21-2025
  • BACK 04-15-2025
  • Dividend Yield
  • MBRX N/A
  • BACK N/A
  • EPS Growth
  • MBRX N/A
  • BACK N/A
  • EPS
  • MBRX N/A
  • BACK N/A
  • Revenue
  • MBRX N/A
  • BACK $72,050.00
  • Revenue This Year
  • MBRX N/A
  • BACK N/A
  • Revenue Next Year
  • MBRX N/A
  • BACK N/A
  • P/E Ratio
  • MBRX N/A
  • BACK N/A
  • Revenue Growth
  • MBRX N/A
  • BACK N/A
  • 52 Week Low
  • MBRX $0.40
  • BACK $0.47
  • 52 Week High
  • MBRX $6.24
  • BACK $7.75
  • Technical
  • Relative Strength Index (RSI)
  • MBRX 46.92
  • BACK 42.28
  • Support Level
  • MBRX $1.55
  • BACK $0.50
  • Resistance Level
  • MBRX $2.22
  • BACK $0.76
  • Average True Range (ATR)
  • MBRX 0.50
  • BACK 0.11
  • MACD
  • MBRX 0.08
  • BACK 0.02
  • Stochastic Oscillator
  • MBRX 27.12
  • BACK 43.33

About MBRX Moleculin Biotech Inc.

Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of resistant tumors and viruses. The company's Annamycin program is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity.

About BACK IMAC Holdings Inc.

IMAC Holdings Inc is a provider and manager of value-based, conservative medical care combining life science advancements with traditional medical care for movement-restricting diseases and conditions in IMAC Regeneration Centers and BackSpace clinics. Its Innovative Medical Advancements and Care (IMAC) Regeneration Centers combine medical and physical procedures to improve patient experiences and outcomes and reduce healthcare costs as compared to other available treatment options.

Share on Social Networks: